Athersys, Inc. (ATHXQ)
0.0000
0.00 (0.00%)
USD |
OTCM |
Aug 28, 16:00
Athersys Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -3.847M |
| June 30, 2023 | -4.585M |
| March 31, 2023 | -5.966M |
| December 31, 2022 | -11.96M |
| September 30, 2022 | -10.38M |
| June 30, 2022 | -16.44M |
| March 31, 2022 | -20.17M |
| December 31, 2021 | -19.33M |
| September 30, 2021 | -19.66M |
| June 30, 2021 | -20.10M |
| March 31, 2021 | -17.09M |
| December 31, 2020 | -17.28M |
| September 30, 2020 | -19.69M |
| June 30, 2020 | -12.74M |
| March 31, 2020 | -12.10M |
| December 31, 2019 | -10.15M |
| September 30, 2019 | -8.214M |
| June 30, 2019 | -11.44M |
| March 31, 2019 | -5.515M |
| December 31, 2018 | -4.566M |
| September 30, 2018 | -7.498M |
| June 30, 2018 | 4.392M |
| March 31, 2018 | -5.678M |
| December 31, 2017 | -6.143M |
| September 30, 2017 | -6.814M |
| Date | Value |
|---|---|
| June 30, 2017 | -5.681M |
| March 31, 2017 | -5.38M |
| December 31, 2016 | -6.284M |
| September 30, 2016 | -5.499M |
| June 30, 2016 | -6.47M |
| March 31, 2016 | 7.322M |
| December 31, 2015 | -5.359M |
| September 30, 2015 | -3.681M |
| June 30, 2015 | -5.84M |
| March 31, 2015 | 1.116M |
| December 31, 2014 | -6.134M |
| September 30, 2014 | -6.249M |
| June 30, 2014 | -6.131M |
| March 31, 2014 | -7.277M |
| December 31, 2013 | -4.514M |
| September 30, 2013 | -5.721M |
| June 30, 2013 | -6.436M |
| March 31, 2013 | -6.113M |
| December 31, 2012 | -3.643M |
| September 30, 2012 | -3.614M |
| June 30, 2012 | -4.991M |
| March 31, 2012 | -5.417M |
| December 31, 2011 | -4.482M |
| September 30, 2011 | -4.161M |
| June 30, 2011 | -4.043M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -177.47M |
| Oncolytics Biotech, Inc. | -8.066M |
| Sangamo Therapeutics, Inc. | -19.28M |
| Sarepta Therapeutics, Inc. | 197.07M |
| Anixa Biosciences, Inc. | -1.741M |